Your browser doesn't support javascript.
loading
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection.
Bavaro, D F; Diella, L; Solimando, A G; Cicco, S; Buonamico, E; Stasi, C; Ciannarella, M; Marrone, M; Carpagnano, F; Resta, O; Carpagnano, G E; Palmieri, V O; Vacca, A; Dell'Aera, M; Dell'Erba, A; Migliore, G; Aricò, M; Saracino, A.
Afiliación
  • Bavaro DF; Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Diella L; Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Solimando AG; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine 'G. Baccelli' University Hospital Policlinico, Bari, Italy.
  • Cicco S; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine 'G. Baccelli' University Hospital Policlinico, Bari, Italy.
  • Buonamico E; Department of Basic Medical Science, Institute of Respiratory Disease, Neuroscience, and Sense Organs, University of Bari "Aldo Moro", Bari, Italy.
  • Stasi C; Clinica Medica 'A. Murri', Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.
  • Ciannarella M; Clinica Medica 'A. Murri', Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.
  • Marrone M; Interdisciplinary Department of Medicine, University of Bari - Section of Legal Medicine, Bari General Hospital, Bari, Italy.
  • Carpagnano F; Section of Health Management, Policlinico Hospital, Bari, Italy.
  • Resta O; Department of Basic Medical Science, Institute of Respiratory Disease, Neuroscience, and Sense Organs, University of Bari "Aldo Moro", Bari, Italy.
  • Carpagnano GE; Department of Basic Medical Science, Institute of Respiratory Disease, Neuroscience, and Sense Organs, University of Bari "Aldo Moro", Bari, Italy.
  • Palmieri VO; Clinica Medica 'A. Murri', Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.
  • Vacca A; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine 'G. Baccelli' University Hospital Policlinico, Bari, Italy.
  • Dell'Aera M; Hospital Pharmacy, Direttore Farmacia Ospedaliera Aou Policlinico Di Bari, Bari, Italy.
  • Dell'Erba A; Interdisciplinary Department of Medicine, University of Bari - Section of Legal Medicine, Bari General Hospital, Bari, Italy.
  • Migliore G; General Direction, Policlinico Hospital, Bari, Italy.
  • Aricò M; Strategic Direction, Policlinico Hospital, Bari, Italy.
  • Saracino A; Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Pathog Glob Health ; 116(5): 297-304, 2022 07.
Article en En | MEDLINE | ID: mdl-35138229
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pathog Glob Health Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pathog Glob Health Año: 2022 Tipo del documento: Article